Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 114, Issue 2, 2001, Pages 281-289

  Drunat, Séverine ^a   Olivi, Martine ^b   Brunie, Ghislaine ^a   Grandchamp, Bernard ^c   Vilmer, Etienne ^b   Bièche, Ivan ^c   Cavé, Hélène ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Lab d'Hematologie Cellulaire Mol   (France)

^c INSERM   (France)

Author keywords

Acute lymphoblastic leukemia; Minimal residual disease; Quantitative RT PCR; TEL AML1

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE FUSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034883770     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02922.x     Document Type: Article

References (34)

1. Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia
2. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications
3. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay
4. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
5. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
6. PCR directly from stool samples: Usefulness of an internal standard
7. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes
8. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
9. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia
10. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression
11. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
12. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
13. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis
14. Quantitative RT-PCR: Pitfalls and potential
15. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive PCR chain reaction
16. Real time quantitative PCR
17. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of thermus aquaficus DNA polymerase
18. Oligonucleotides with fluorescent dye at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
19. Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy
20. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
21. Quantitation of minimal residual disease in Philadelphia chromosome-positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR
22. Rapid and sensitive minimal residual disease detection in acute lymphoblastic leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript
23. A simplified method for determination of specific DNA or RNA copy number using quantitative PCR and an automatic DNA sequencer
24. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay
25. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
26. The 12:21 translocation involving tel and deletion of the other tel allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia
27. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
28. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukemia with t(12;21)
29. TEL-AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
30. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical reslapse
31. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
32. Long term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report
33. Comparison of nested competitive RT-PCR and real-time PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia
34. TEL/AML1 positivity in childhood ALL: Average or better prognosis?